Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             80 results found
no title author magazine year volume issue page(s) type
1 Application of superparamagnetic iron oxide (AMI-227) for 3D phase-contrast MR angiography Tanimoto, Akihiro
1998
5 S1 p. S113-S115
3 p.
article
2 Assessment of acute and reperfused myocardial ischemia using GdDTPA, GdDTPA-cascade-24-polymer and albumin-GdDTPA Roberts, H.C.
1998
5 S1 p. S31-S33
3 p.
article
3 Blood-Pool contrast agents for MRI: A critical evaluation Koenig, Seymour H.
1998
5 S1 p. S200-S205
6 p.
article
4 Can contrast media act as “Pseudoantigens”? Lasser, Elliott C.
1998
5 S1 p. S95-S98
4 p.
article
5 Clinical experience with AF0150 (Imagent US), a new ultrasound contrast agent Pelura, Timothy J.
1998
5 S1 p. S69-S71
3 p.
article
6 Clinical usefulness of iomeprol 400 mgl/mL in cardioangiography evaluation of patient discomfort and hemodynamic and ECG effects Himi, Kazuhisa
1998
5 S1 p. S54-S57
4 p.
article
7 Contrast-enhanced magnetic resonance angiography in the coronary and peripheral arteries Saeed, Maythem
1998
5 S1 p. S108-S112
5 p.
article
8 Contrast-enhanced MR angiography and first-pass renal perfusion imaging using MS-325, an intravascular contrast agent Prasad, Pottumarthi V.
1998
5 S1 p. S219-S222
4 p.
article
9 Contrast-enhanced MRI of focal liver lesions: Differentiation and detection of primary and secondary liver lesions using resovist-enhanced versus gadolinium-enhanced MRI in the same patient Hammerstingl, Renate
1998
5 S1 p. S75-S79
5 p.
article
10 Contrast enhancement of the liver in healthy male volunteers following intravenous administration of FP 736-04 Magnusson, Anders
1998
5 S1 p. S9-S12
4 p.
article
11 Contrast-enhancement properties of irradiated normal lymph nodes: Initial experience with interstitially delivered iodinated nanoparticles Wisner, Erik R.
1998
5 S1 p. S180-S182
3 p.
article
12 Delayed adverse reaction of monomeric contrast media: Comparison of plain CT and enhanced CT Munechika, H.
1998
5 S1 p. S157-S158
2 p.
article
13 Delayed hypersensitivity to X-ray CM: Possible mechanisms and models Speck, Ulrich
1998
5 S1 p. S162-S165
4 p.
article
14 Development of a novel nonaromatic small-molecule MR contrast agent for the blood pool Adzamli, Kofi
1998
5 S1 p. S210-S213
4 p.
article
15 Diagnostic improvement of renal ultrasonography in humans after IV injection of perflenapent emulsion Correas, Jean-Michel
1998
5 S1 p. S185-S188
4 p.
article
16 Discussion for session 2 1998
5 S1 p. S28-S30
3 p.
article
17 Discussion for session 5 1998
5 S1 p. S72-S74
3 p.
article
18 Discussion for session 11 1998
5 S1 p. S156-
1 p.
article
19 Discussion for session 12 1998
5 S1 p. S166-
1 p.
article
20 Discussion for session 14 1998
5 S1 p. S199-
1 p.
article
21 Discussion for Session 15 1998
5 S1 p. S226-S227
2 p.
article
22 Discussion for session 9 1998
5 S1 p. S131-S132
2 p.
article
23 Discussion for session 4 1998
5 S1 p. S60-S62
3 p.
article
24 Discussion for session 7 1998
5 S1 p. S106-S107
2 p.
article
25 Discussion for session 13 1998
5 S1 p. S183-S184
2 p.
article
26 Discussion for session 10 1998
5 S1 p. S145-S146
2 p.
article
27 Discussion for session 6 1998
5 S1 p. S93-S94
2 p.
article
28 Discussion for session 16 1998
5 S1 p. S234-S235
2 p.
article
29 Discussion for session 17 1998
5 S1 p. S252-S253
2 p.
article
30 Discussion for session 3 1998
5 S1 p. S45-S46
2 p.
article
31 Drug eruption caused by nonionic iodinated X-ray contrast media Akiyama, Masaki
1998
5 S1 p. S159-S161
3 p.
article
32 Dynamic susceptibility contrast MR imaging for the evaluation of probable Alzheimer disease: A cost-effectiveness analysis LaFrance, Norman D.
1998
5 S1 p. S231-S233
3 p.
article
33 Dysprosium EOB DTPA: A new liver-specific contrast agent for computed tomography Schuhmann-Giampieri, Gabriele
1998
5 S1 p. S90-S92
3 p.
article
34 Effect of steroid pretreatment on contrast media-induced potassium release Hayakawa, Katsumi
1998
5 S1 p. S99-S101
3 p.
article
35 Efficacy and safety of liver-specific MRI contrast agents in rats with hepatitis and cirrhosis Kato, Naoki
1998
5 S1 p. S83-S85
3 p.
article
36 Efficacy of the hepatocyte-specific contrast medium FP 736-04 for CT in two models of experimental diffuse liver disease Bergman, Antonina
1998
5 S1 p. S13-S15
3 p.
article
37 Enhanced detection of thrombi with a novel fibrin-targeted magnetic resonance imaging agent Lanza, Gregory M.
1998
5 S1 p. S173-S176
4 p.
article
38 Enhancement of power Doppler signals from breast lesions with the ultrasound contrast agent EchoGen emulsion: Subjective and quantitative assessment Albrecht, Thomas
1998
5 S1 p. S195-S198
4 p.
article
39 Evaluation of Gd-DOTA-labeled dextran polymer as an intravascular MR contrast agent for myocardial perfusion Casali, Cendrine
1998
5 S1 p. S214-S218
5 p.
article
40 Evaluation of new thrombus-specific ultrasound contrast agent Wright Jr, William H.
1998
5 S1 p. S240-S242
3 p.
article
41 Evaluation of N,N′-bis-dimethyldiatrizoic acid analogs as liver imaging agents Ranganathan, R.S.
1998
5 S1 p. S23-S27
5 p.
article
42 Experimental hepatic dysfunction: Evaluation by MR imaging with Gd-EOB-DTPA Murakami, Takamichi
1998
5 S1 p. S80-S82
3 p.
article
43 Factors determining tumor contrast enhancement—Time curves Dawson, Peter
1998
5 S1 p. S228-S230
3 p.
article
44 Good resolution of contrast-enhanced MRA using USPIO on coronal plane acquisition: Experimental evaluation of time-of-flight effect using flow phantom and animal study Tobe, Kimiko
1998
5 S1 p. S116-S118
3 p.
article
45 High-resolution harmonic gray-scale imaging of normal and abnormal vessels and tissues in animals Mattrey, Robert F.
1998
5 S1 p. S63-S65
3 p.
article
46 Human pharmacokinetics and modeling of the concentration-attenuation relationship of a new liposomal liver-specific contrast agent for CT Höglund, Peter
1998
5 S1 p. S47-S48
2 p.
article
47 Influence of iotrolan on renal cortical and outer medullary blood flow in the rat Liss, Per
1998
5 S1 p. S123-S126
4 p.
article
48 Investigation of MR contrast media utility with the VX-2 tumor model Runge, Val M.
1998
5 S1 p. S34-S36
3 p.
article
49 Involvement of the lung in the histamine-releasing effects of iodinated contrast media Corot, Claire
1998
5 S1 p. S102-S105
4 p.
article
50 Kinetics of a novel blood pool agent (MP-2269) with persistent high relaxivity for MR angiography Hofman, Mark B.M.
1998
5 S1 p. S206-S209
4 p.
article
51 Lipid-based blood-pool CT imaging of the liver Weichert, Jamey P.
1998
5 S1 p. S16-S19
4 p.
article
52 Liver-tumor detection with ultrasound contrast: A blinded prospective study in rabbits Girard, Michael S.
1998
5 S1 p. S189-S191
3 p.
article
53 Macromolecular contrast media—enhanced MRI estimates of microvascular permeability correlate with histopathologic tumor grade Brasch, Robert C.
1998
5 S1 p. S2-S5
4 p.
article
54 MR imaging of lymph nodes in patients with primary abdominal and pelvic malignancies using ultrasmall superparamagnetic iron oxide (Combidex) Harisinghani, Mukesh G.
1998
5 S1 p. S167-S169
3 p.
article
55 MR lymphography: Evidence of extravasation of superparamagnetic nanoparticles into the lymph Clement, Olivier
1998
5 S1 p. S170-S172
3 p.
article
56 MRX 501: A novel ultrasound contrast agent with therapeutic properties Unger, Evan C.
1998
5 S1 p. S247-S249
3 p.
article
57 Multicenter evaluation of the safety, tolerance, and efficacy of OptiMARK in magnetic resonance imaging of the brain and spine Grossman, Robert
1998
5 S1 p. S154-S155
2 p.
article
58 MultiHance clinical pharmacology: Biodistribution and MR enhancement of the liver Spinazzi, Alberto
1998
5 S1 p. S86-S89
4 p.
article
59 Multisite study of the safety and efficacy of LumenHance, a new gastrointestinal contrast agent for MRI of the abdomen and pelvis Small, W.C.
1998
5 S1 p. S147-S150
4 p.
article
60 New liposomal liver-specific contrast agent for CT: First human phase I clinical trial assessing efficacy and safety Leander, Peter
1998
5 S1 p. S6-S9
4 p.
article
61 Optimizing imaging techniques to reduce errors in microvascular quantitation with macromolecular MR contrast agents Roberts, T.P.L.
1998
5 S1 p. S133-S136
4 p.
article
62 Pharmacokinetic and hemodynamic safety of two superparamagnetic agents, endorem and sinerem, in cirrhotic rats Bonnemain, Bruno
1998
5 S1 p. S151-S153
3 p.
article
63 Phase II, placebo-controlled trial of MRX115 (Aerosomes) for left heart and myocardial perfusion imaging Pantely, George A.
1998
5 S1 p. S66-S68
3 p.
article
64 Preface Katayama, Hitoshi
1998
5 S1 p. S1-
1 p.
article
65 Prospective randomized crossover pilot study of the safety and efficacy of carbon dioxide versus iodinated contrast for peripheral angiography Oliva, Vincent
1998
5 S1 p. S58-S59
2 p.
article
66 Receptor-mediated mechanisms in contrast medium—induced renal vasoconstriction Drescher, Peter
1998
5 S1 p. S119-S122
4 p.
article
67 Safety and pharmacokinetics of BR21, a liver-specific CT agent, in healthy volunteers Spinazzi, Alberto
1998
5 S1 p. S20-S22
3 p.
article
68 Safety of carbon dioxide as a contrast medium in cerebral angiography Wilson, Alan J.
1998
5 S1 p. S51-S53
3 p.
article
69 Safety of Levovist injection in patients undergoing exercise stress echocardiography: A placebo-controlled study Wiggins, Jay R.
1998
5 S1 p. S192-S194
3 p.
article
70 Selection of contrast medium for CT: What percentage of patients receiving CT needs nonionic contrast media (low-osmolarity contrast media)? Michael Mu Huo Teng,
1998
5 S1 p. S49-S50
2 p.
article
71 Simultaneous use of Gd-DTPA and spin-lock imaging: A phantom study Ramadan, Usama Abo
1998
5 S1 p. S141-S144
4 p.
article
72 Stimulated acoustic emission imaging (“Sono-scintigraphy”) with the ultrasound contrast agent Levovist: A reproducible Doppler ultrasound effect with potential clinical utility Blomley, Martin
1998
5 S1 p. S236-S239
4 p.
article
73 T1 and T2 relaxometry of monocrystalline iron oxide nanoparticles (MION-46L): Theory and experiment Bulte, Jeff W.M.
1998
5 S1 p. S137-S140
4 p.
article
74 Targeting of ultrasound contrast material: Selective imaging of microbubbles in vitro Klibanov, Alexander L.
1998
5 S1 p. S243-S246
4 p.
article
75 Toward necrotic cell fraction measurement by contrast-enhanced MRI of reperfused ischemically injured myocardium Wendland, Michael F.
1998
5 S1 p. S42-S44
3 p.
article
76 Use of intravascular contrast agents in MRI Bjørnerud, Atle
1998
5 S1 p. S223-S225
3 p.
article
77 Use of intravenous Optison contrast echocardiography reduces downstream resource use and enhances cost savings Shaw, Leslee J.
1998
5 S1 p. S250-S251
2 p.
article
78 Validation of intracoronary delivery of metalloporphyrin as an in vivo “Histochemical staining” for myocardial infarction with MR imaging Yicheng, Ni
1998
5 S1 p. S37-S41
5 p.
article
79 Visualizing renal anatomy and function with 1–10,000-nm radiocontrast agents Wolf, Gerald L
1998
5 S1 p. S127-S130
4 p.
article
80 X-ray phototherapy for solid tumors Norman, Amos
1998
5 S1 p. S177-S179
3 p.
article
                             80 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands